Congressional appropriators instructed NIH to cut spending on communications activities and coordinate the broad range of activities that fall under the category of public relations.
FDA approved Miltenyi Biotec's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from a matched related donor.
The Susan G. Komen Breast Cancer Foundation reported a 22 percent decline in contributions in fiscal 2013—totalling over $77 million—in recent financial statements.
The Community Oncology Alliance and the American Society of Clinical Oncology issued a joint statement on payment reform in cancer care and proposed alternative approaches to paying for cancer care.
BAYLOR COLLEGE OF MEDICINE, CHI St. Luke's Health and the Texas Heart Institute have expanded their educational, clinical and research affiliations in conjunction with Catholic Health Initiatives, which sponsors and operates the newly named CHI St. Luke's Health.
REGENERON PHARMACEUTICALS Inc. and Geisinger Health System announced a research collaboration focused on studying the genetic determinants of human disease.
MD ANDERSON CANCER CENTER and Pfizer will collaborate in the development of immune-based approaches to cancer treatment, the first such agreement made through MD Anderson's Moon Shots Program immunotherapy platform.
DMITRI ALDEN was named an Honorary Foreign Member of the French National Academy of Surgery. He will be officially recognized at the academy's 2014 Solemn Ceremony Jan. 22 in Paris.
BARBARA ANN BURTNESS was named clinical research program leader of the Head and Neck Cancers Program at Smilow Cancer Hospital at Yale-New Haven and co-director of the Developmental Therapeutics Research Program for Yale Cancer Center. She will become a professor of medicine in medical oncology and will begin her appointment April 1.
The Howard Hughes Medical Institute is seeking to appoint up to 25 new biomedical researchers through a national open competition. The initiative represents an investment of approximately $150 million in basic biomedical research over the next five years.
